|
|
Volumn 7, Issue 4, 2002, Pages 223-226
|
|
William Pardridge discusses the lack of BBB research
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID;
BRAIN DERIVED NEUROTROPHIC FACTOR;
COMPLEMENTARY DNA;
EPIDERMAL GROWTH FACTOR;
NEUROPROTECTIVE AGENT;
NEUROTROPHIN;
PEPTIDE;
RADIOPHARMACEUTICAL AGENT;
VIRUS VECTOR;
COMPLEMENTARY RNA;
ALZHEIMER DISEASE;
BLOOD BRAIN BARRIER;
BRAIN CANCER;
BRAIN DISEASE;
BRAIN SCINTISCANNING;
BRAIN TUMOR;
CELL CULTURE;
COLON CANCER;
CYTOLOGY;
DRUG INDUSTRY;
DRUG PROGRAM;
DRUG TARGETING;
DRUG TRANSPORT;
ENDOTHELIUM CELL;
GENE EXPRESSION;
GENE TARGETING;
HEALTH CARE COST;
HUMAN;
MODEL;
MOLECULAR BIOLOGY;
MOLECULAR SIZE;
NEUROPROTECTION;
NONHUMAN;
PHYSICIAN;
PROTEOMICS;
REVIEW;
STROKE;
THEORY;
ARTICLE;
FINANCIAL MANAGEMENT;
GENE THERAPY;
INTERVIEW;
PHYSIOLOGY;
RESEARCH;
BLOOD-BRAIN BARRIER;
DRUG INDUSTRY;
GENE THERAPY;
HUMANS;
NEUROPROTECTIVE AGENTS;
RESEARCH;
RESEARCH SUPPORT;
RNA, ANTISENSE;
|
|
EID: 0037083385
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(02)02195-5 Document Type: Short Survey |
|
Times cited : (35)
|
|
References (0)
|
